Company

Novo Nordisk Opens Its Next Chapter With 'Lasting Health Starts Now' Rebrand and 'The Novo Way' Culture – Single 'Novo' Name Signals a Faster, Consumer‑Driven Era
Novo NordiskNYSE: NVO

Novo Nordisk Opens Its Next Chapter With ‘Lasting Health Starts Now’ Rebrand and ‘The Novo Way’ Culture – Single ‘Novo’ Name Signals a Faster, Consumer‑Driven Era

Novo Nordisk (NYSE: NVO) today unveiled a corporate rebrand centred on "Lasting Health Starts Now" and the single "Novo" name, together with an updated corporate culture, "The Novo Way", designed…

Sichuan Biokin's HER2 ADC T‑Bren Doses First Patient in Phase III Neoadjuvant Breast Cancer Trial – Head‑to‑Head Test Against Standard TCBHP Regimen

Sichuan Biokin’s HER2 ADC T‑Bren Doses First Patient in Phase III Neoadjuvant Breast Cancer Trial – Head‑to‑Head Test Against Standard TCBHP Regimen

Henlius' Denosumab Biosimilar HLX14 Gains NMPA BLA Acceptance – Fosun Pharma Subsidiary Targets Full Xgeva Label for China's Bone Health Market

Henlius’ Denosumab Biosimilar HLX14 Gains NMPA BLA Acceptance – Fosun Pharma Subsidiary Targets Full Xgeva Label for China’s Bone Health Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Novo Nordisk Sales Reach DKK 309 Billion on GLP‑1 and Obesity Surge
Finanical ReportsNovo Nordisk

Novo Nordisk Sales Reach DKK 309 Billion on GLP‑1 and Obesity Surge

AbbVieHKG: 2096

Simcere Receives $40M Milestone from AbbVie for Trispecific Myeloma Drug

MedtronicNYSE: MDT

Medtronic to Acquire CathWorks for $585M, Expand AI-Based FFRangio System

TenNor Therapeutics Files Hong Kong IPO for Anti-Infective Pipeline
BiotechIPO

TenNor Therapeutics Files Hong Kong IPO for Anti-Infective Pipeline

Show More